Sandip Patel, MD - UCSD - June "Researcher of the Month"

Sandip Patel, MD - UCSD - June "Researcher of the Month"Подробнее

Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse eventsПодробнее

Sandip Patel, MD: Comprehensive Genomic ProfilingПодробнее

Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapiesПодробнее

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapiesПодробнее

Sandip Patel, MD | Perspective on Cancer Care in the Time of COVID-19Подробнее

Sandip Patel, MD, considers immunotherapy combinations and the likelihood of severe adverse eventsПодробнее

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of lifeПодробнее

ASCO22 Local Lung Cancer Updates | Sandip Patel, MD | University of San DiegoПодробнее

ALK+ lung cancer hope from Dr. Sandip Patel UC San Diego #AACR19 #AACRSSP19 #ATLПодробнее

Sandip Patel, MD, on treating non-squamous NSCLC patients expressing high levels of PD-L1Подробнее

Dr. Patel on Novel Agents for Patients With NSCLCПодробнее

Copy of Dr. Patel on Novel Agents for Patients With NSCLCПодробнее

Lung Cancer Video Library - Evolving Standards for Molecular Testing in Advanced NSCLCПодробнее

Sandip Patel, MD, comments on the top stories in lung cancer from ASCO 2019Подробнее

Infectious Disease Breakthroughs - Medicine Informing Novel Discoveries (MIND)Подробнее

ASCO 2021 Clinical Panel Series - Lung CancerПодробнее

Sandip Patel, MD | Addressing Patients on Cancer Care in the Time of COVID-19Подробнее

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agentsПодробнее

Sandip Patel, MD, speculates on the impact of the RELAY trial presented at ASCO 2019Подробнее